thymidine has been researched along with oridonin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandobashi, K; Ikezoe, T; Koeffler, HP; Machida, H; Saito, T; Taguchi, H; Takemoto, S; Togitani, K; Yang, Y | 1 |
1 other study(ies) available for thymidine and oridonin
| Article | Year |
|---|---|
Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; bcl-X Protein; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Proliferation; Diterpenes; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Genes, Reporter; Human T-lymphotropic virus 1; Humans; In Situ Nick-End Labeling; Isodon; Jurkat Cells; Leukemia; Lipopolysaccharides; Male; Mice; Middle Aged; Models, Chemical; Multiple Myeloma; NF-kappa B; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; T-Lymphocytes; Thymidine; Time Factors; Transfection; Trypan Blue | 2005 |